Diastolic function predicts survival after renal revascularization

Purpose The purpose of this study was to define the relationship between left ventricular diastolic function and survival after renal revascularization. Methods Seventy-six adult patients (49 women, 27 men; mean age: 63 ± 13 years) with preoperative echocardiography who underwent renal revasculariza...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of vascular surgery 2011-12, Vol.54 (6), p.1720-1726.e1
Hauptverfasser: Ghanami, Racheed J., MD, Rana, Hamza, MD, Craven, Timothy E., MSPH, Hoyle, John, MD, MPH, Edwards, Matthew S., MD, MS, Hansen, Kimberley J., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1726.e1
container_issue 6
container_start_page 1720
container_title Journal of vascular surgery
container_volume 54
creator Ghanami, Racheed J., MD
Rana, Hamza, MD
Craven, Timothy E., MSPH
Hoyle, John, MD, MPH
Edwards, Matthew S., MD, MS
Hansen, Kimberley J., MD
description Purpose The purpose of this study was to define the relationship between left ventricular diastolic function and survival after renal revascularization. Methods Seventy-six adult patients (49 women, 27 men; mean age: 63 ± 13 years) with preoperative echocardiography who underwent renal revascularization for atherosclerotic disease were identified. Diastolic function was estimated from the early diastolic transmitral flow velocity (E), the atrial transmitral flow velocity (A), and the mitral annular tissue doppler velocity (e′). Patients were divided into two groups of diastolic dysfunction as either none/mild (E/A ≤0.75, E/e′ 0.75, E/e′ ≥10). Perioperative and follow-up mortality were determined from a prospective vascular database and the National Death Index. Descriptive statistics were calculated and postoperative survival was estimated by product-limit methods. Associations between preoperative factors, perioperative factors, and follow-up survival were examined using proportional hazards regression models. A forward stepwise variable selection procedure was used to select a “best” model to predict follow-up survival. Results Seventy-six patients were followed for an average of 41.9 months after renal revascularization. Within this group, 47 of 76 patients (61.8%) were identified as having moderate or severe diastolic dysfunction. Diastolic dysfunction had no apparent association with abnormal systolic function. The mean ejection fraction for those with moderate/severe diastolic dysfunction was 57.7% ± 11.5%. When comparing the moderate/severe and none/mild groupings of diastolic dysfunction, there was a significant difference in left ventricular mass index (151.9 ± 48.9 vs 125.3 ± 31.7; P = .0087). There were five deaths in the perioperative period and 20 deaths on follow-up. Among perioperative survivors, hypertension was cured or improved in 82% of the none/mild group and 53% of the moderate/severe group ( P = .012). In multivariable analysis, none/mild diastolic dysfunction was significantly and independently associated with an improvement in blood pressure after revascularization (odds ratio [OR], 6.2; 95% confidence interval [CI], 1.4-28.6; P = .018). Ejection fraction was not associated with survival. After forward variable selection, moderate/severe diastolic dysfunction (hazard ratio [HR], 5.8; 95% CI 1.4-25; P = .018) was the only variable to demonstrate a significant and independent association with follow-up su
doi_str_mv 10.1016/j.jvs.2011.05.091
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3230744</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521411013334</els_id><sourcerecordid>908743147</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-bb9bf03c08f0f73c855d66c06a5562be6e50acf3fd1e43bb2a2c8bb3035ac0ba3</originalsourceid><addsrcrecordid>eNp9kl2L1TAQhoMo7nH1B3gjvRGvWidJ0w-EhXX9hAUv1OuQTCea2tMek7aw_npTznH9uPAqgTzzZnhmGHvMoeDAq-d90a-xEMB5AaqAlt9hOw5tnVcNtHfZDuqS50rw8ow9iLGHBKqmvs_OBG8Elw3s2MtX3sR5Gjxmbhlx9tOYHQJ1HueYxSWsfjVDZtxMIQs0pnug1URcBhP8D7PxD9k9Z4ZIj07nOfv85vWnq3f59Ye3768ur3NUUs25ta11IBEaB66W2CjVVRVCZZSqhKWKFBh00nWcSmmtMAIbayVIZRCskefs4ph7WOyeOqRxDmbQh-D3JtzoyXj998vov-ov06qlkMlEmQKenQLC9H2hOOu9j0jDYEaalqhbaOpS8rJOJD-SGKYYA7nbXzjoTb3udVKvN_UalE7qU82TP9u7rfjlOgFPT0DyZwYXzIg-_uaUqATUVeJeHDlKMldPQUf0NGIaSiCcdTf5_7Zx8U81Dn706cNvdEOxn5aQphg111Fo0B-3HdlWhKc8KWUpfwJDeLjn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>908743147</pqid></control><display><type>article</type><title>Diastolic function predicts survival after renal revascularization</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ghanami, Racheed J., MD ; Rana, Hamza, MD ; Craven, Timothy E., MSPH ; Hoyle, John, MD, MPH ; Edwards, Matthew S., MD, MS ; Hansen, Kimberley J., MD</creator><creatorcontrib>Ghanami, Racheed J., MD ; Rana, Hamza, MD ; Craven, Timothy E., MSPH ; Hoyle, John, MD, MPH ; Edwards, Matthew S., MD, MS ; Hansen, Kimberley J., MD</creatorcontrib><description>Purpose The purpose of this study was to define the relationship between left ventricular diastolic function and survival after renal revascularization. Methods Seventy-six adult patients (49 women, 27 men; mean age: 63 ± 13 years) with preoperative echocardiography who underwent renal revascularization for atherosclerotic disease were identified. Diastolic function was estimated from the early diastolic transmitral flow velocity (E), the atrial transmitral flow velocity (A), and the mitral annular tissue doppler velocity (e′). Patients were divided into two groups of diastolic dysfunction as either none/mild (E/A ≤0.75, E/e′ &lt;10) or moderate/severe (E/A &gt;0.75, E/e′ ≥10). Perioperative and follow-up mortality were determined from a prospective vascular database and the National Death Index. Descriptive statistics were calculated and postoperative survival was estimated by product-limit methods. Associations between preoperative factors, perioperative factors, and follow-up survival were examined using proportional hazards regression models. A forward stepwise variable selection procedure was used to select a “best” model to predict follow-up survival. Results Seventy-six patients were followed for an average of 41.9 months after renal revascularization. Within this group, 47 of 76 patients (61.8%) were identified as having moderate or severe diastolic dysfunction. Diastolic dysfunction had no apparent association with abnormal systolic function. The mean ejection fraction for those with moderate/severe diastolic dysfunction was 57.7% ± 11.5%. When comparing the moderate/severe and none/mild groupings of diastolic dysfunction, there was a significant difference in left ventricular mass index (151.9 ± 48.9 vs 125.3 ± 31.7; P = .0087). There were five deaths in the perioperative period and 20 deaths on follow-up. Among perioperative survivors, hypertension was cured or improved in 82% of the none/mild group and 53% of the moderate/severe group ( P = .012). In multivariable analysis, none/mild diastolic dysfunction was significantly and independently associated with an improvement in blood pressure after revascularization (odds ratio [OR], 6.2; 95% confidence interval [CI], 1.4-28.6; P = .018). Ejection fraction was not associated with survival. After forward variable selection, moderate/severe diastolic dysfunction (hazard ratio [HR], 5.8; 95% CI 1.4-25; P = .018) was the only variable to demonstrate a significant and independent association with follow-up survival. Conclusion Diastolic dysfunction, but not systolic dysfunction, was frequent in patients with renovascular disease. Blood pressure response and follow-up survival after renal revascularization demonstrated significant and independent associations with diastolic function. Consideration of diastolic function should be included in the management of patients with atherosclerotic renovascular disease.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2011.05.091</identifier><identifier>PMID: 21821380</identifier><identifier>CODEN: JVSUES</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Blood Pressure - physiology ; Cohort Studies ; Diastole - physiology ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Predictive Value of Tests ; Renal Artery Obstruction - mortality ; Renal Artery Obstruction - physiopathology ; Renal Artery Obstruction - therapy ; Renovascular diseases ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Survival Rate ; Treatment Outcome ; Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels ; Vascular Surgical Procedures ; Ventricular Function, Left - physiology</subject><ispartof>Journal of vascular surgery, 2011-12, Vol.54 (6), p.1720-1726.e1</ispartof><rights>Society for Vascular Surgery</rights><rights>2011 Society for Vascular Surgery</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.</rights><rights>2011 The Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-bb9bf03c08f0f73c855d66c06a5562be6e50acf3fd1e43bb2a2c8bb3035ac0ba3</citedby><cites>FETCH-LOGICAL-c535t-bb9bf03c08f0f73c855d66c06a5562be6e50acf3fd1e43bb2a2c8bb3035ac0ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0741521411013334$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25262076$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21821380$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ghanami, Racheed J., MD</creatorcontrib><creatorcontrib>Rana, Hamza, MD</creatorcontrib><creatorcontrib>Craven, Timothy E., MSPH</creatorcontrib><creatorcontrib>Hoyle, John, MD, MPH</creatorcontrib><creatorcontrib>Edwards, Matthew S., MD, MS</creatorcontrib><creatorcontrib>Hansen, Kimberley J., MD</creatorcontrib><title>Diastolic function predicts survival after renal revascularization</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Purpose The purpose of this study was to define the relationship between left ventricular diastolic function and survival after renal revascularization. Methods Seventy-six adult patients (49 women, 27 men; mean age: 63 ± 13 years) with preoperative echocardiography who underwent renal revascularization for atherosclerotic disease were identified. Diastolic function was estimated from the early diastolic transmitral flow velocity (E), the atrial transmitral flow velocity (A), and the mitral annular tissue doppler velocity (e′). Patients were divided into two groups of diastolic dysfunction as either none/mild (E/A ≤0.75, E/e′ &lt;10) or moderate/severe (E/A &gt;0.75, E/e′ ≥10). Perioperative and follow-up mortality were determined from a prospective vascular database and the National Death Index. Descriptive statistics were calculated and postoperative survival was estimated by product-limit methods. Associations between preoperative factors, perioperative factors, and follow-up survival were examined using proportional hazards regression models. A forward stepwise variable selection procedure was used to select a “best” model to predict follow-up survival. Results Seventy-six patients were followed for an average of 41.9 months after renal revascularization. Within this group, 47 of 76 patients (61.8%) were identified as having moderate or severe diastolic dysfunction. Diastolic dysfunction had no apparent association with abnormal systolic function. The mean ejection fraction for those with moderate/severe diastolic dysfunction was 57.7% ± 11.5%. When comparing the moderate/severe and none/mild groupings of diastolic dysfunction, there was a significant difference in left ventricular mass index (151.9 ± 48.9 vs 125.3 ± 31.7; P = .0087). There were five deaths in the perioperative period and 20 deaths on follow-up. Among perioperative survivors, hypertension was cured or improved in 82% of the none/mild group and 53% of the moderate/severe group ( P = .012). In multivariable analysis, none/mild diastolic dysfunction was significantly and independently associated with an improvement in blood pressure after revascularization (odds ratio [OR], 6.2; 95% confidence interval [CI], 1.4-28.6; P = .018). Ejection fraction was not associated with survival. After forward variable selection, moderate/severe diastolic dysfunction (hazard ratio [HR], 5.8; 95% CI 1.4-25; P = .018) was the only variable to demonstrate a significant and independent association with follow-up survival. Conclusion Diastolic dysfunction, but not systolic dysfunction, was frequent in patients with renovascular disease. Blood pressure response and follow-up survival after renal revascularization demonstrated significant and independent associations with diastolic function. Consideration of diastolic function should be included in the management of patients with atherosclerotic renovascular disease.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - physiology</subject><subject>Cohort Studies</subject><subject>Diastole - physiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Predictive Value of Tests</subject><subject>Renal Artery Obstruction - mortality</subject><subject>Renal Artery Obstruction - physiopathology</subject><subject>Renal Artery Obstruction - therapy</subject><subject>Renovascular diseases</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><subject>Vascular Surgical Procedures</subject><subject>Ventricular Function, Left - physiology</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kl2L1TAQhoMo7nH1B3gjvRGvWidJ0w-EhXX9hAUv1OuQTCea2tMek7aw_npTznH9uPAqgTzzZnhmGHvMoeDAq-d90a-xEMB5AaqAlt9hOw5tnVcNtHfZDuqS50rw8ow9iLGHBKqmvs_OBG8Elw3s2MtX3sR5Gjxmbhlx9tOYHQJ1HueYxSWsfjVDZtxMIQs0pnug1URcBhP8D7PxD9k9Z4ZIj07nOfv85vWnq3f59Ye3768ur3NUUs25ta11IBEaB66W2CjVVRVCZZSqhKWKFBh00nWcSmmtMAIbayVIZRCskefs4ph7WOyeOqRxDmbQh-D3JtzoyXj998vov-ov06qlkMlEmQKenQLC9H2hOOu9j0jDYEaalqhbaOpS8rJOJD-SGKYYA7nbXzjoTb3udVKvN_UalE7qU82TP9u7rfjlOgFPT0DyZwYXzIg-_uaUqATUVeJeHDlKMldPQUf0NGIaSiCcdTf5_7Zx8U81Dn706cNvdEOxn5aQphg111Fo0B-3HdlWhKc8KWUpfwJDeLjn</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Ghanami, Racheed J., MD</creator><creator>Rana, Hamza, MD</creator><creator>Craven, Timothy E., MSPH</creator><creator>Hoyle, John, MD, MPH</creator><creator>Edwards, Matthew S., MD, MS</creator><creator>Hansen, Kimberley J., MD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20111201</creationdate><title>Diastolic function predicts survival after renal revascularization</title><author>Ghanami, Racheed J., MD ; Rana, Hamza, MD ; Craven, Timothy E., MSPH ; Hoyle, John, MD, MPH ; Edwards, Matthew S., MD, MS ; Hansen, Kimberley J., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-bb9bf03c08f0f73c855d66c06a5562be6e50acf3fd1e43bb2a2c8bb3035ac0ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - physiology</topic><topic>Cohort Studies</topic><topic>Diastole - physiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Predictive Value of Tests</topic><topic>Renal Artery Obstruction - mortality</topic><topic>Renal Artery Obstruction - physiopathology</topic><topic>Renal Artery Obstruction - therapy</topic><topic>Renovascular diseases</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</topic><topic>Vascular Surgical Procedures</topic><topic>Ventricular Function, Left - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ghanami, Racheed J., MD</creatorcontrib><creatorcontrib>Rana, Hamza, MD</creatorcontrib><creatorcontrib>Craven, Timothy E., MSPH</creatorcontrib><creatorcontrib>Hoyle, John, MD, MPH</creatorcontrib><creatorcontrib>Edwards, Matthew S., MD, MS</creatorcontrib><creatorcontrib>Hansen, Kimberley J., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghanami, Racheed J., MD</au><au>Rana, Hamza, MD</au><au>Craven, Timothy E., MSPH</au><au>Hoyle, John, MD, MPH</au><au>Edwards, Matthew S., MD, MS</au><au>Hansen, Kimberley J., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diastolic function predicts survival after renal revascularization</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>54</volume><issue>6</issue><spage>1720</spage><epage>1726.e1</epage><pages>1720-1726.e1</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><coden>JVSUES</coden><abstract>Purpose The purpose of this study was to define the relationship between left ventricular diastolic function and survival after renal revascularization. Methods Seventy-six adult patients (49 women, 27 men; mean age: 63 ± 13 years) with preoperative echocardiography who underwent renal revascularization for atherosclerotic disease were identified. Diastolic function was estimated from the early diastolic transmitral flow velocity (E), the atrial transmitral flow velocity (A), and the mitral annular tissue doppler velocity (e′). Patients were divided into two groups of diastolic dysfunction as either none/mild (E/A ≤0.75, E/e′ &lt;10) or moderate/severe (E/A &gt;0.75, E/e′ ≥10). Perioperative and follow-up mortality were determined from a prospective vascular database and the National Death Index. Descriptive statistics were calculated and postoperative survival was estimated by product-limit methods. Associations between preoperative factors, perioperative factors, and follow-up survival were examined using proportional hazards regression models. A forward stepwise variable selection procedure was used to select a “best” model to predict follow-up survival. Results Seventy-six patients were followed for an average of 41.9 months after renal revascularization. Within this group, 47 of 76 patients (61.8%) were identified as having moderate or severe diastolic dysfunction. Diastolic dysfunction had no apparent association with abnormal systolic function. The mean ejection fraction for those with moderate/severe diastolic dysfunction was 57.7% ± 11.5%. When comparing the moderate/severe and none/mild groupings of diastolic dysfunction, there was a significant difference in left ventricular mass index (151.9 ± 48.9 vs 125.3 ± 31.7; P = .0087). There were five deaths in the perioperative period and 20 deaths on follow-up. Among perioperative survivors, hypertension was cured or improved in 82% of the none/mild group and 53% of the moderate/severe group ( P = .012). In multivariable analysis, none/mild diastolic dysfunction was significantly and independently associated with an improvement in blood pressure after revascularization (odds ratio [OR], 6.2; 95% confidence interval [CI], 1.4-28.6; P = .018). Ejection fraction was not associated with survival. After forward variable selection, moderate/severe diastolic dysfunction (hazard ratio [HR], 5.8; 95% CI 1.4-25; P = .018) was the only variable to demonstrate a significant and independent association with follow-up survival. Conclusion Diastolic dysfunction, but not systolic dysfunction, was frequent in patients with renovascular disease. Blood pressure response and follow-up survival after renal revascularization demonstrated significant and independent associations with diastolic function. Consideration of diastolic function should be included in the management of patients with atherosclerotic renovascular disease.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>21821380</pmid><doi>10.1016/j.jvs.2011.05.091</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 2011-12, Vol.54 (6), p.1720-1726.e1
issn 0741-5214
1097-6809
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3230744
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Adult
Aged
Biological and medical sciences
Blood Pressure - physiology
Cohort Studies
Diastole - physiology
Female
Humans
Male
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
Predictive Value of Tests
Renal Artery Obstruction - mortality
Renal Artery Obstruction - physiopathology
Renal Artery Obstruction - therapy
Renovascular diseases
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Survival Rate
Treatment Outcome
Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels
Vascular Surgical Procedures
Ventricular Function, Left - physiology
title Diastolic function predicts survival after renal revascularization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T03%3A13%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diastolic%20function%20predicts%20survival%20after%20renal%20revascularization&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Ghanami,%20Racheed%20J.,%20MD&rft.date=2011-12-01&rft.volume=54&rft.issue=6&rft.spage=1720&rft.epage=1726.e1&rft.pages=1720-1726.e1&rft.issn=0741-5214&rft.eissn=1097-6809&rft.coden=JVSUES&rft_id=info:doi/10.1016/j.jvs.2011.05.091&rft_dat=%3Cproquest_pubme%3E908743147%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=908743147&rft_id=info:pmid/21821380&rft_els_id=S0741521411013334&rfr_iscdi=true